BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31178306)

  • 1. Bilateral oculomotor nerve palsy in a case of anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
    Yasuda K; Maki T; Takata M; Kimura K; Takahashi T; Kanbayashi T; Murase N; Ohtani R; Takahashi R; Nakamura M
    J Clin Neurosci; 2019 Aug; 66():271-272. PubMed ID: 31178306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder associated with esophageal cancer.
    Kon T; Ueno T; Suzuki C; Nunomura J; Igarashi S; Sato T; Tomiyama M
    J Neuroimmunol; 2017 Aug; 309():38-40. PubMed ID: 28601284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder subsequent to rhabdomyolysis: a case report and literature review.
    Shang K; Qin C; Bu BT; Tian DS
    Int J Neurosci; 2019 Sep; 129(9):930-932. PubMed ID: 30722721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.
    Kamo H; Ueno Y; Sugiyama M; Miyamoto N; Yamashiro K; Tanaka R; Yokoyama K; Hattori N
    J Neuroimmunol; 2019 May; 330():19-22. PubMed ID: 30769213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection in a woman with aquaporin-4 seropositive neuromyelitis optica.
    Naresh K; Miraclin TA; Prabhakar AT; Mathew V; Sivadasan A; Moorthy M; Prakash JAJ; Mathews DA; Benjamin RN
    J Neuroimmunol; 2021 Jul; 356():577581. PubMed ID: 33940232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
    Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
    Tao S; Zhang Y; Ye H; Guo D
    Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
    Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
    J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder.
    Asato Y; Kamitani T; Ootsuka K; Kuramochi M; Nakanishi K; Shimada T; Takahashi T; Misu T; Aoki M; Fujihara K; Kawabata Y
    Intern Med; 2018 Oct; 57(20):2981-2986. PubMed ID: 29780127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
    Lee J; Jeong SH; Park SM; Sohn EH; Lee AY; Kim JM; Jo HJ; Lee YH; Kim JS
    Mult Scler; 2015 Apr; 21(4):477-80. PubMed ID: 25013154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaze palsy, hypogeusia and a probable association with miscarriage of pregnancy--the expanding clinical spectrum of non-opticospinal neuromyelitis optica spectrum disorders: a case report.
    Chang T; Withana M
    BMC Res Notes; 2015 Feb; 8():36. PubMed ID: 25888897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patients.
    Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Antunes Barreira A; Armas E; Chiganer E; de Aquino Cruz C; Di Pace JL; Hryb JP; Lavigne Moreira C; Lessa C; Molina O; Perassolo M; Soto A; Caride A
    Mult Scler Relat Disord; 2018 Jan; 19():73-78. PubMed ID: 29156226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report.
    Narumi Y; Yoshida R; Minami Y; Yamamoto Y; Takeguchi S; Kano K; Takahashi K; Saito T; Sawada J; Terui H; Katayama T; Sasaki T; Ohsaki Y
    BMC Cancer; 2018 Jan; 18(1):95. PubMed ID: 29361915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report.
    Bejerot S; Hesselmark E; Mobarrez F; Wallén H; Hietala MA; Nybom R; Wetterberg L
    J Med Case Rep; 2019 Jan; 13(1):27. PubMed ID: 30696485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma: A Case Report and Literature Review.
    Ikeguchi R; Shimizu Y; Shimomura A; Suzuki M; Shimoji K; Motohashi T; Yamamoto T; Shibata N; Kitagawa K
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34285095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced sarcolemmal aquaporin 4 expression can support the differential diagnosis of neuromyelitis optica spectrum disorders.
    Zhang W; Dong M; Dong H; Wang W; Sun W; Hao Y; Jiao Y; Cui L; Jiao J
    J Neuroimmunol; 2020 Feb; 339():577121. PubMed ID: 31786498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-aquaporin-4 antibody-seronegative NMO spectrum disorder with Baló's concentric lesions.
    Masuda H; Mori M; Katayama K; Kikkawa Y; Kuwabara S
    Intern Med; 2013; 52(13):1517-21. PubMed ID: 23812202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab.
    Breu M; Glatter S; Höftberger R; Freilinger M; Kircher K; Kasprian G; Seidl R; Kornek B
    Neuropediatrics; 2019 Jun; 50(3):193-196. PubMed ID: 30913570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Sun H; Cui S; Gao F; You Q; Li Y; Wang J; Zhang X
    J Neurol Sci; 2018 Jan; 384():91-95. PubMed ID: 29249386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.